Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Internal Radiation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Large-scale testing (Phase 3)UnknownNCT00278278
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
German Society for Pediatric Oncology and Hematology GPOH gGmbH 150
Testing effectiveness (Phase 2)Looking for participantsNCT05979610
What this trial is testing

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Who this might be right for
Gynecologic NeoplasmBrachytherapyTherapeutic Touch+4 more
University of Utah 70
Testing effectiveness (Phase 2)Looking for participantsNCT03541928
What this trial is testing

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Who this might be right for
High-risk Prostate CancerProstate Cancer
The Methodist Hospital Research Institute 60
Not applicableLooking for participantsNCT03246802
What this trial is testing

Partial Prostate Salvage High Dose Rate Brachytherapy

Who this might be right for
Recurrent Prostate Cancer
British Columbia Cancer Agency 30
Testing effectiveness (Phase 2)UnknownNCT02342054
What this trial is testing

Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospital de Cruces 49
Not applicableStudy completedNCT01706705
What this trial is testing

Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 57
Not applicableLooking for participantsNCT05047094
What this trial is testing

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma
Alpha Tau Medical LTD. 48
Testing effectiveness (Phase 2)Study completedNCT00542490
What this trial is testing

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer

Who this might be right for
Endometrial CancerPapillary SerousClear Cell Endometrial Cancer
University of Oklahoma 23
Not applicableStudy completedNCT00807820
What this trial is testing

Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 10
Large-scale testing (Phase 3)Study completedNCT00193830
What this trial is testing

High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix

Who this might be right for
Cancer of CervixCervical CancerCancer of the Cervix+1 more
Tata Memorial Hospital 750
Testing effectiveness (Phase 2)Looking for participantsNCT05009992
What this trial is testing

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Who this might be right for
Diffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-MutantRecurrent Diffuse Intrinsic Pontine Glioma+3 more
University of California, San Francisco 360
Not applicableUnknownNCT01285674
What this trial is testing

Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

Who this might be right for
CisplatinOtotoxicityIntratympanic Steroids
Ziv Hospital 20
Not applicableUnknownNCT04127435
What this trial is testing

High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors

Who this might be right for
Cervical Cancer
Peking University Third Hospital 50
Not applicableNot Yet RecruitingNCT06062589
What this trial is testing

AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 18
Post-approval studies (Phase 4)Ended earlyNCT00699101
What this trial is testing

Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy

Who this might be right for
Breast Cancer
SenoRx, Inc. 342
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07654257
What this trial is testing

Single FrAction Interstitial BreaSt BracHytherApy

Who this might be right for
Breast Cancer
Virginia Commonwealth University 134
Not applicableLooking for participantsNCT05715502
What this trial is testing

Focal Salvage Brachytherapy Study (FocaSaBra)

Who this might be right for
Prostate Cancer
The Greater Poland Cancer Centre 100
Not applicableStudy completedNCT01899404
What this trial is testing

MRI FDG PET Imaging Cervix

Who this might be right for
Cervical Cancer Squamous Cell
University Health Network, Toronto 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663487
What this trial is testing

A Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sirtex Medical 78
Next Page